Preparative regimens for patients with leukemias and severe aplastic anemia (overview) : biological basis, experimental animal studies and clinical trials at the Fred Hutchinson Cancer Research Center
Storb, R.
Bone Marrow Transplantation 14(Suppl 4): S1-S3
1994
ISSN/ISBN: 0268-3369 PMID: 7728117 Document Number: 435903
Two purposes are served by conditioning regimens for allogeneic BMT. One is to suppress the patient's immune system so the foreign graft can take. The other purpose is to eliminate the underlying disease for which the patient is transplanted. This report reviews the recent developments in areas of conditioning programs for patients with aplastic anemia and hematological malignancies.
Document emailed within 1 workday
Related Documents
Mornati, S. 1995: Ampliamento di un centro di ricerche nediche a Seattle - Fred Hutchinson cancer research center, Seattle - Extension d'un centre de recherches médicales à Seattle Industria Delle Costruzioni 29(280): 40-45Lopez, K.D.; Guinan, E.C. 1995: GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia Pediatric Nursing 21(4): 345-349
Lanovenko, I.I.; Hashchuk, H.P. 2005: Experimental basis for using hypoxic training in the correction of oxygen transport system damage in aplastic anemia Fiziolohichnyi Zhurnal 51(5): 43-49
Arranz, R.; Otero, M.J.; Ramos, R.; Steegmann, J.L.; Lamana, M.L.; Tomás, J.F.; de la Cámara, R.; Figuera, A.; Vázquez, L.; Fernádez-Rañada, J.M. 1994: Clinical results in 50 multiply transfused patients with severe aplastic anemia treated with bone marrow transplantation or immunosuppressive therapy Bone Marrow Transplantation 13(4): 383-387
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Vadhan-Raj, S. 1992: Clinical trials of granulocyte-macrophage colony-stimulating factor for the treatment of aplastic anemia Immunology Series 57: 661-670
Dalzell, M.D. 2018: Fred Hutchinson Report Plots The Nexus of Cost and Quality Managed Care 27(7): 8-9
González-Barca, E.; Domingo, A.; Fernández de Sevilla, A.; Grañena, A. 1995: Clinical course of severe acquired aplastic anemia to myelodysplastic syndrome and acute leukosis Medicina Clinica 105(6): 224-226
Liu, C.-Y.; Fu, R.; Wang, J.; Liang, Y.; Qu, W.; Ruan, E.-B.; Wang, H.-Q.; Li, L.-J.; Liu, H.; Wang, G.-J.; Liu, H.; Wu, Y.-H.; Wang, X.-M.; Song, J.; Xing, L.-M.; Guan, J.; Wang, H.-L.; Zhang, T.; Liu, X.; Shao, Z.-H. 2012: Expression of lymphokines in CD8(+)HLA-DR(+) T lymphocytes of patients with severe aplastic anemia Zhonghua Yi Xue Za Zhi 92(18): 1240-1243
Shibata, A.; Sanada, M.; Ashizawa, T. 1978: Aplastic anemia as a stem cell failure: studies of biological models for hematopoietic cells and sites of disorder using colony formation method Nihon Rinsho. Japanese Journal of Clinical Medicine 36(7): 2634-2640
Okubo, H.; Okamoto, Y.; Fujii, Y. 1978: Aplastic anemia induced by chloramphenicol--clinical studies Nihon Rinsho. Japanese Journal of Clinical Medicine 36(7): 2728-2733
Grgicević, D.; Labar, B.; Bogdanić, V.; Kerhin-Brkljacić, V.; Kastelan, A. 1985: Transfusion therapy in patients with severe aplastic anemia after bone marrow transplantation Lijecnicki Vjesnik 107(2): 85-89
Wang, T.; Fu, R.; Wang, H.-q.; Qu, W.; Ruan, E.-b.; Wang, G.-j.; Liu, H.; Wu, Y.-h.; Wang, X.-m.; Song, J.; Xing, L.-m.; Guan, J.; Li, L.-j.; Liu, H.; Liu, C.-y.; Wang, Y.-h.; Jiang, H.-j.; Ding, K.; Dong, X.-f.; Wang, H.-l.; Zhang, T.; Shao, Z.-h. 2013: Telomere length and gene expression of shelterin in CD3(+) T cell of severe aplastic anemia patients Zhonghua Yi Xue Za Zhi 93(20): 1533-1536
Ding, S.; Fu, R.; Zhang, J.; Li, L.; Liu, H.; Liu, C.; Wang, H.; Zhang, T.; Ding, K.; Qu, W.; Ruan, E.; Wang, G.; Song, J.; Wang, H.; Wang, X.; Guan, J.; Liu, H.; Wu, Y.; Shao, Z. 2014: In vitro functions of natural killer cells in peripheral blood of patients with severe aplastic anemia Zhonghua Yi Xue Za Zhi 94(48): 3845-3847
Wan, L.; Yan, S.; Wang, C.; Yang, X.; Zhou, Z.; Gao, Y.; Cai, Q.; Zhang, B. 2003: Allogeneic peripheral blood stem cell transplantation in the treatment of severe aplastic anemia and severe infection Chinese Medical Journal 116(5): 676-678
Bacigalupo, A.; Podesta', M.; Raffo, M.R.; Piaggio, G.; Van Lint, M.T.; Vimercati, R.; Spriano, V.M.; Risso, M.; Marmont, A.M. 1980: Lack of in vitro colony (CFUC) formation and myelosuppressive activity in patients with severe aplastic anemia after autologous hematologic reconstitution Experimental Hematology 8(6): 795-801
Nomura, T. 1992: Japanese clinical statistical data of patients with aplastic anemia Nihon Rinsho. Japanese Journal of Clinical Medicine 50 Suppl: 735-746
Lee, J.H.; Lee, J.H.; Lee, J.S.; Kim, W.K.; Chi, H.S.; Lee, K.H. 2001: Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings Haematologica 86(4): 434-435
Issaragrisil, S. 1999: Epidemiology of aplastic anemia in Thailand. Thai Aplastic Anemia Study Group International Journal of Hematology 70(3): 137-140
Ivy, S.P.; Blatner, G.; Cheson, B.D. 1999: Clinical trials referral resource. Clinical trials of combination regimens containing oxaliplatin Oncology 13(8): 1116-1118